The UK must plug an increasing number of science skills gaps to maintain its world-leading position for medicines and vaccines research and development, says the ABPI.
Patients could have access to new, ground-breaking medicines up to six months earlier and the NHS across the UK is expected to save around £930 million on its medicine bill under a new scheme being finalised between the pharmaceutical industry and the Government.
The ABPI and BIA have submitted a joint submission in response to the MHRA and DHSC consultation on 'no deal' contingency legislation for medicines and devices regulation for the UK.
The value of Scotland’s pharmaceutical industry is revealed today in a new report by the Fraser of Allander Institute which shows the significant contribution the sector makes to all parts of the Scottish economy.
This afternoon the Chancellor delivered the Budget 2018 with details of additional funding for the NHS, £1.6 billion in new investments for the modern industrial strategy and increased allocations for Brexit preparations.
The Medicines and Healthcare products Regulatory Agency (MHRA) has opened a consultation on how its legislation and regulatory processes would have to be modified in the event of the UK not securing a deal with the EU after the UK’s exit, with no Implementation Period.
In a week where the Office of Health Economics (OHE) has published a report on the ten most important medicines over the life of the NHS, Dr Sheuli Porkess outlines how the pharmaceutical industry takes a substance from molecule to medicine and how the process requires persistance.
Elliot Dunster, Head of External Affairs at the ABPI, takes a closer look at the 'no deal' guidance published by Government.
Parliament has voted in favour of amendment NC17 to the Trade Bill that will make it a negotiating objective for the UK Government to seek the UK's participation in the European medicines regulatory network.
The UK government have today published a White Paper detailing their position on ‘The Future Relationship between the United Kingdom and the European Union’.